CIK: 0001668029 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $7,468 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ABG ACQUISITION CORP I | 501,300 | $5,058 | 67.7% | $9.89 | — | CL A SHS | G00496102 |
| — | SONENDO INC | 547,945 | $1,551 | 20.8% | $5.76 | — | COM | 835431107 |
| CSTL | CASTLE BIOSCIENCES INC | 20,592 | $485 | 6.5% | $23.24 | -0.2% | COM | 14843C105 |
| — | APEXIGEN INC | 401,757 | $274 | 3.7% | $2.70 | — | COM | 03759B102 |
| — | AEGLEA BIOTHERAPEUTICS INC | 112,044 | $50 | 0.7% | $7.87 | — | COM | 00773J103 |
| — | PRENETICS GLOBAL LTD | 25,000 | $50 | 0.7% | $4.04 | — | CLASS A ORD | G72245106 |